METTL14 attenuates cancer stemness by suppressing ATF5 / WDR74 /β‐catenin axis in gastric cancer
Cancer Science · 2025
DOI: 10.1111/cas.16381 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Peiling Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Methyltransferases, beta Catenin, Activating Transcription Factors. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Natural Science Foundation of Guangdong Province, Guangzhou Science and Technology Program, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Stemness is a key factor contributing to treatment failure in gastric cancer (GC). Methyltransferase‐like 14 (METTL14) has been linked to various cancers, though its specific role in regulating stemness in GC remains undefined. In this study, we assessed METTL14 expression levels in GC tissues using public datasets and clinical specimens and investigated its impact on cell proliferation, metastasis, and stemness both in vitro and in vivo. Through m6A RNA immunoprecipitation (MeRIP) and luciferase reporter assays, we identified downstream targets of METTL14. Rescue assays were performed to examine whether METTL14 overexpression could reverse stemness in GC. We also explored the underlying mechanisms using chromatin immunoprecipitation (ChIP) and western blot analysis, focusing on the role of ATF5 and the upstream regulation of METTL14. Our findings show that lower METTL14 expression is associated with poorer overall survival in GC patients. Functionally, METTL14 knockdown enhanced stemness traits in GC cells. Mechanistically, METTL14 facilitated m6A modification, promoting the degradation of ATF5 mRNA. Overexpression of ATF5 reversed the stemness inhibition caused by METTL14 overexpression by increasing WDR74 transcription and enhancing β‐catenin nuclear translocation. Furthermore, histone H3 lactylation at Lys18 was found to upregulate METTL14 expression. In conclusion, METTL14 knockdown promotes stemness in GC by mediating m6A modification of ATF5 mRNA, which activates the WDR74/β‐catenin axis, making METTL14 a potential therapeutic target for gastric cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China.
- Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medica University.
ORCID-Profile: Lujuan Ma, Guolong Liu, Lin Lu
Förderung
- the Natural Science Foundation of Guangdong Province
- Guangzhou Science and Technology Program
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Zhang, P., Xiang, H., Peng, Q., Ma, L., Weng, C., Liu, G., & Lu, L. (2025). METTL14 attenuates cancer stemness by suppressing ATF5 / WDR74 /β‐catenin axis in gastric cancer. Cancer Science. https://doi.org/10.1111/cas.16381
Vancouver
Zhang P, Xiang H, Peng Q, Ma L, Weng C, Liu G, et al. METTL14 attenuates cancer stemness by suppressing ATF5 / WDR74 /β‐catenin axis in gastric cancer. Cancer Science. 2025. doi:10.1111/cas.16381
BibTeX
@article{Zhang2025,
author = {Zhang, Peiling and Xiang, Hong and Peng, Qian and Ma, Lujuan and Weng, Chengyin and Liu, Guolong and Lu, Lin},
title = {METTL14 attenuates cancer stemness by suppressing ATF5 / WDR74 /β‐catenin axis in gastric cancer},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.16381}
}
EUVIMED